Covered recipient · General Payments record
TRINI GARZA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,960.46
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $466.85 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $262.26 | 17 |
| Amgen Inc. | $44.65 | 3 |
| Atland Pharmaceuticals, LLC | $41.96 | 1 |
| Lilly USA, LLC | $40.96 | 2 |
| Acerta Pharma LLC | $30.33 | 2 |
| PFIZER INC. | $16.15 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.45 | 1 |
| Novo Nordisk AS | $15.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.96 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779435 | CMS |
| ABBVIE INC. | $22.74 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779437 | CMS |
| ABBVIE INC. | $12.23 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779439 | CMS |
| ABBVIE INC. | $6.88 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779441 | CMS |
| ABBVIE INC. | $6.53 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779443 | CMS |
| ABBVIE INC. | $16.43 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779445 | CMS |
| ABBVIE INC. | $26.74 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779447 | CMS |
| ABBVIE INC. | $16.15 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779449 | CMS |
| ABBVIE INC. | $12.56 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779451 | CMS |
| ABBVIE INC. | $26.33 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779453 | CMS |
| ABBVIE INC. | $12.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779455 | CMS |
| ABBVIE INC. | $15.38 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779457 | CMS |
| ABBVIE INC. | $12.04 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779459 | CMS |
| ABBVIE INC. | $22.61 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779461 | CMS |
| ABBVIE INC. | $22.95 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779463 | CMS |
| ABBVIE INC. | $5.85 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779465 | CMS |
| ABBVIE INC. | $11.88 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103779467 | CMS |
| Amgen Inc. | $15.96 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560314 | CMS |
| Amgen Inc. | $14.92 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560316 | CMS |
| Amgen Inc. | $13.77 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115650375 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.88 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104302110 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.45 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104500004 | CMS |
| Atland Pharmaceuticals, LLC | $41.96 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067526567 | CMS |
| Lilly USA, LLC | $20.93 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135468321 | CMS |
| Lilly USA, LLC | $20.03 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135461310 | CMS |
| Novo Nordisk Inc | $15.09 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097046406 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.45 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118896526 | CMS |
| PFIZER INC. | $16.15 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131930950 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.